换一批
换一批
作者：
C,Meyer [1]
;
P,Larghero [1]
;
B,Almeida Lopes [1]
;
T,Burmeister [2]
;
D,Gröger [3]
;
R,Sutton [3]
;
N C,Venn [4]
;
G,Cazzaniga [4]
;
L,Corral Abascal [5]
;
G,Tsaur [5]
;
L,Fechina [6]
;
M,Emerenciano [6]
;
M S,Pombo-de-Oliveira [2]
;
T,Lund-Aho [2]
;
T,Lundán [7]
;
M,Montonen [8]
;
V,Juvonen [8]
;
J,Zuna [8]
;
J,Trka [9]
;
P,Ballerini [9]
;
H,Lapillonne [10]
;
V H J,Van der Velden [10]
;
E,Sonneveld [11]
;
E,Delabesse [12]
;
R R C,de Matos [13]
;
M L M,Silva [14]
;
S,Bomken [14]
;
K,Katsibardi [15]
;
M,Keernik [16]
;
N,Grardel [17]
;
J,Mason [18]
;
R,Price [19]
;
J,Kim [19]
;
C,Eckert [1]
;
L,Lo Nigro [20]
;
C,Bueno [21]
;
P,Menendez [22]
;
U,Zur Stadt [23]
;
P,Gameiro [24]
;
L,Sedék [22]
;
T,Szczepański [25]
;
A,Bidet [26]
;
V,Marcu [27]
;
K,Shichrur [27]
;
S,Izraeli [28]
;
H O,Madsen [29]
;
B W,Schäfer [30]
;
S,Kubetzko [31]
;
R,Kim [32]
;
E,Clappier [33]
;
H,Trautmann [33]
;
M,Brüggemann [34]
;
P,Archer [35]
;
J,Hancock [34]
;
J,Alten [35]
;
A,Möricke [36]
;
M,Stanulla [36]
;
J,Lentes [37]
;
A K,Bergmann [37]
;
S,Strehl [38]
;
S,Köhrer [38]
;
K,Nebral [39]
;
M N,Dworzak [40]
;
O A,Haas [40]
;
C,Arfeuille [41]
;
A,Caye-Eude [41]
;
H,Cavé [42]
;
R,Marschalek [41]
作者单位：
DCAL/Institute of Pharm. Biology, Goethe-University, Frankfurt/Main, Germany.
[1]
Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.
[2]
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Dept. of Hematology, Oncology and Tumor Immunology, Berlin, Germany.
[3]
Molecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia.
[4]
Tettamanti Research Center, Pediatrics, University of Milano-Bicocca/Fondazione Tettamanti, Monza, Italy.
[5]
Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
[6]
Laboratory of Clinical Genetics, Fimlab Laboratories, Tampere, Finland.
[7]
Department of Clinical Chemistry and Laboratory Division, University of Turku and Turku University Hospital, Turku, Finland.
[8]
CLIP, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
[9]
Biological Hematology, AP-HP A. Trousseau, Pierre et Marie Curie University, Paris, France.
[10]
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
[11]
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
[12]
Institut Universitaire du Cancer de Toulouse, Toulouse Cedex 9, France.
[13]
Cytogenetics Department, Bone Marrow Transplantation Unit, National Cancer Institute (INCA), Rio de Janeiro, Brazil.
[14]
Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
[15]
Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.
[16]
Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
[17]
Department of Hematology, CHU Lille, France.
[18]
Northern Institute for Cancer Research, Newcastle University and the Great North Children's West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's NHS Foundation Trust, Mindelsohn Way, Birmingham, United Kingdom.
[19]
Department of Laboratory Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
[20]
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Oncology/Hematology, Berlin, Germany.
[21]
Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Azienda Policlinico "G. Rodolico", Catania, Italy.
[22]
Josep Carreras Leukemia Research Institute. Barcelona, Spanish Network for Advanced Therapies (RICORS-TERAV, ISCIII); Spanish Collaborative Cancer Network (CIBERONC. ISCIII); University of Barcelona, Barcelona, Spain.
[23]
Josep Carreras Leukemia Research Institute. Barcelona, Spanish Network for Advanced Therapies (RICORS-TERAV, ISCIII); Spanish Collaborative Cancer Network (CIBERONC. ISCIII); Department of Biomedicine. University of Barcelona; and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
[24]
Pediatric Hematology and Oncology and CoALL Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[25]
Instituto Português de Oncologia, Departament of Hematology, Lisbon, Portugal.
[26]
Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland.
[27]
Laboratoire d'Hématologie Biologique, CHU Bordeaux, Bordeaux, France.
[28]
Hematology Laboratory, Sheba Medical Center, Tel-Hashomer, Israel.
[29]
Molecular Oncology Laboratory, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
[30]
Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
[31]
Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
[32]
Division of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.
[33]
Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
[34]
Université Paris Cité, INSERM/CNRS U944/UMR7212, Institut de recherche Saint-Louis, Paris, France.
[35]
Laboratory for Specialized Hematological Diagnostics, Medical Department II, University Hospital Schleswig-Holstein, Kiel, Germany.
[36]
Bristol Genetics Laboratory, North Bristol NHS Trust, Bristol, United Kingdom.
[37]
Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
[38]
Department of Pediatrics, MHH, Hanover, Germany.
[39]
Institute of Human Genetics, Medical School Hannover, Hannover, Germany.
[40]
St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
[41]
Labdia Labordiagnostik, Vienna, Austria.
[42]
St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
[43]
Genetics Department, AP-HP, Hopital Robert Debré, Paris, France.
[44]
Université Paris Cité, Inserm U1131, Institut de recherche Saint-Louis, Paris, France.
[45]
DCAL/Institute of Pharm. Biology, Goethe-University, Frankfurt/Main, Germany. Rolf.Marschalek@em.uni-frankfurt.de.
[46]
主题词
人类(Humans);婴儿(Infant);儿童, 学龄前(Child, Preschool);儿童(Child);青少年(Adolescent);成年人(Adult);中年人(Middle Aged);老年人(Aged);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);组蛋白赖氨酸N-甲基转移酶(Histone-Lysine N-Methyltransferase);髓淋巴细胞性白血病蛋白质(Myeloid-Lymphoid Leukemia Protein);基因融合(Gene Fusion)
DOI
10.1038/s41375-023-01877-1
PMID
37019990
发布时间
2024-02-14
- 浏览8
Leukemia
Leukemia
988-1005页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
